Obtaining CME Credit
The CME online evaluation will be available through November 4, 2011. After that date, the site will be removed and certificates will no longer be available. If you need a CME certificate and have not paid the $50 application fee, please contact the ASBMR Business Office at email@example.com or by phone at + 1 (202) 367-1161.
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the Institute for the Advancement of Human Behavior (IAHB) and the American Society for Bone and Mineral Research. The IAHB is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation Statement
The IAHB designates this live activity for a maximum of 35.5 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Upon returning home from the meeting, participants should be able to:
- Identify and discuss the most current and significant advances in biomedical and clinical research in bone and mineral metabolism, specifically in the areas of muscle and bone, vitamin d, calcium supplementation, mineral metabolism, genetics, osteoporosis, musculoskeletal diseases, metabolic bone diseases and therapeutics.
- Better understand the interrelationship among basic research, clinical research and patient care.
- Improve their ability to treat and care for their patients through an enhanced knowledge of osteoporosis, other diseases of bone, basic bone biology and its correlation to mineral metabolism.
- Develop new and enhanced strategies for the diagnosis and treatment of patients with disorders of bone and mineral metabolism.
The program is designed for researchers, physicians and other health and allied health professionals with interests in biomechanics, endocrinology, physiology, cell biology, metabolism and musculoskeletal research, pathology, molecular biology, genetics, epidemiology, internal medicine, rheumatology, orthopaedics, dentistry, nephrology, and pharmacology.
ASBMR Expectations of Authors and Presenters
Through ASBMR meetings, the Society promotes excellence in bone and mineral research. To that end, ASBMR expects that all authors and presenters affiliated with the ASBMR 2011 Annual Meeting and the 2011 Ancillary Program will provide informative and fully accurate content that reflects the highest level of scientific rigor and integrity. ASBMR depends upon the honesty of the authors and presenters and relies on their assertions that they have had sufficient full access to the data and are convinced of its reliability. Furthermore, ASBMR expects that:
- Authors and presenters will disclose any conflicts of interest, real or perceived.
- Authors of an abstract describing a study funded by an organization with a proprietary or financial interest must affirm that they had full access to all the data in the study. By so doing, they accept complete responsibility for the integrity of the data and the accuracy of the data analysis.
- The content of abstracts, presentations, slides and reference materials must remain the ultimate responsibility of the author(s) or faculty.
- The planning, content and execution of abstracts, speaker presentations, slides, abstracts and reference materials should be free from corporate influence, bias or control.
- All authors and presenters (invited and abstracts-based oral and poster presenters) should give a balanced view of therapeutic options by providing several treatment options, whenever possible, and by always citing the best available evidence.
In addition, ASBMR's meeting evaluations will seek feedback regarding commercial bias at ASBMR Annual Meeting sessions, including the 2011 Ancillary Program.
Disclosure/Conflict of Interest Statement
The American Society for Bone and Mineral Research is committed to ensuring the balance, independence, objectivity and scientific rigor of all its individually sponsored or industry-supported educational activities. Accordingly, the ASBMR adheres to the requirement set by ACCME that audiences at jointly sponsored educational programs be informed of a presenter's (speaker, faculty, author or planner) academic and professional affiliations, and the disclosure of the existence of any significant financial interest or other relationship a presenter or their spouse has with any proprietary entity over the past twelve months producing, marketing, re-selling or distributing health care goods or services, consumed by, or used on patients, with the exemption of non-profit or government organizations and non-health care related companies. When an unlabeled use of a commercial product, or an investigational use not yet approved for any purpose, is discussed during the presentation, it is required that presenters disclose that the product is not labeled for the use under discussion or that the product is still investigational. This policy allows the listener/attendee to be fully knowledgeable in evaluating the information being presented. Within this On-Site Program book it is noted those speakers who have disclosed relationships, including the nature of the relationship and the associated commercial entity.
Disclosure should include any relationship that may bias one's presentation or which, if known, could give the perception of bias. This includes relevant financial relationships of a spouse or partner. Disclosures will be printed in the program materials. These situations may include, but are not limited to: 1) Stock options or bond holdings in a for-profit corporation or self-directed pension plan; 2) Research grants; 3) Employment (full or part-time); 4) Ownership or partnership; 5) Consulting fees or other remuneration (payment); 6) Non-remunerative positions of influence such as officer, board member, trustee or public spokesperson; 7) Receipt of royalties; 8) Speaker's bureau; 9) Other.
Disclosures for invited speakers and abstract presenters are provided at the end of the session listing. The disclosure information will correspond to the key above. If disclosures are given, the company name, along with the respective disclosure relationship number will be listed (for example: Company Name 2, 8.)